News and Announcements
Edison Investment Research Initiates Coverage on Prescient Therapeutics
- Published March 04, 2016 10:22AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
3rd March 2016, ASX Announcement
Edision Investment Research Limited has initiated coverage of clinical stage oncology company Prescient Therapeutics Limited (ASX: PTX).
The full report can be found under the Media/Press & Research Reports tab on the Company’s website www.prescienttherapeutics.com or found on Edison Investment Limited’s website at www.edisoninvestmentresearch.com by clicking to the Research tab, selecting Sector Reports and under the sector Health Care.
To read the full announcement, please click here.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
